We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Portable Immunoassay System Advances Toward Point-of-Care Biomarker Testing

By HospiMedica International staff writers
Posted on 11 Jun 2026

Proxim Diagnostics Corp. More...

(Santa Clara, CA, USA) has announced that its Profile System, a handheld point-of-care immunoassay platform, has completed development. The milestone includes completion of the reader, single-use cartridge, and initial manufacturing capability. The fully automated, portable system is designed to deliver high-sensitivity biomarker testing at the point of care and is now positioned for production readiness and potential partnerships in acute care and research applications.

The technology integrates a disposable cartridge with a compact reader to execute immunoassays intended to deliver centralized laboratory performance closer to the bedside. The Profile System is designed as a flexible architecture capable of supporting multiple assay types on the same handheld reader. The company indicates this may enable a broad test menu over time, including research‑use‑only (RUO) assays for biopharma customers and future clinical assays that would be subject to applicable regulatory requirements.

Proxim is advancing applications in acute care biomarkers, including cardiac and inflammatory markers where rapid point‑of‑care results can support time‑critical decisions. The platform has demonstrated key analytical traits associated with high‑sensitivity troponin testing. In testing of its high‑sensitivity troponin I assay, the system achieved an 81% detectable rate in the normal population.

The company also highlights RUO assays for cytokines such as interleukin‑6, interferon‑gamma, and CXCL9 for inpatient and outpatient use by biopharma clients developing T‑cell engager therapies, where rapid cytokine measurements may support prediction, monitoring, and management of cytokine release syndrome (CRS), immune effector cell‑associated neurotoxicity syndrome (ICANS), hemophagocytic lymphohistiocytosis (HLH), and other immuno‑oncology therapy‑related adverse effects.

“Completing development of our handheld reader, cartridge, and initial manufacturing capacity is a major milestone for Proxim. We now have a fully developed product platform that is ready to support high-value clinical and RUO opportunities,” said Mikhail Briman, Ph.D., CEO and co-founder of Proxim Diagnostics.

“Our goal has always been to bring the sensitivity and precision of centralized laboratory testing into a portable point-of-care format, and this achievement puts us in a strong position to engage strategic partners and customers across biopharma, acute care, women’s health, and other important clinical and research areas,” added Briman.

Related Links
Proxim Diagnostics


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Radiofrequency Generator
GX1
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Business

view channel
From left: Mr Ng Tian Chong, Chief Executive Officer, Singtel Singapore; Professor Yeoh Khay Guan, Chief Executive, NUHS; and Mr Daniel Ode, Head of Ericsson Singapore, Brunei and Philippines and Global Customer Unit Singtel, signed a Memorandum of Understanding to advance connected healthcare, 5G-Advanced and 6G technology, as well as connected intelligence. (Photo courtesy of National University Health System)

Healthcare Partnership Creates Testbed for Advanced Connectivity and AI Applications

Hospitals face growing care complexity, aging populations, and pressure to extend monitoring beyond traditional inpatient settings. Meeting these demands requires more responsive clinical workflows and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.